Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma

Published:2023-11 Issue: Volume:278-279 Page:62-70
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Qian Huiwen,Hou Chunqi,Zhang Yi,Ji Shundong,Zhong Chongke,Li Juan,Zhang Qianqian,Huang Jianan,Li Chong,ChengJi

Funder

Suzhou City Department of Science and Technology

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference50 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin Cancer Res.,2013

3. EGFR mutations and lung cancer;da Cunha Santos;Annu Rev Pathol,2011

4. Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: mechanisms and therapeutic strategies;Lim;Cancer Treat Rev,2018

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;New Eng J Med,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in biomarker identification and validation for oral cancer diagnosis and prognosis;Oral Oncology Reports;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP